๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Validation of a new prognostic index for patients with chronic lymphocytic leukemia

โœ Scribed by Tait D. Shanafelt; Greg Jenkins; Timothy G. Call; Clive S. Zent; Susan Slager; Deborah A. Bowen; Susan Schwager; Curtis A. Hanson; Diane F. Jelinek; Neil E. Kay


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
205 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Multicentre validation of a prognostic i
โœ Pietro Bulian; Michela Tarnani; Davide Rossi; Francesco Forconi; Giovanni Del Po ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 379 KB ๐Ÿ‘ 1 views

We wish to validate in a multicentric CLL population a nomogram and a risk score recently developed to predict overall survival (OS). Complete records from 1037 CLL patients were retrospectively collected to estimate OS and time to treatment (TTT). Cox models were used to test the independence of ag

Prognostic value of plasma interleukin-6
โœ Raymond Lai; Susan O'Brien; Taghi Maushouri; Anna Rogers; Hagop Kantarjian; Mich ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 78 KB ๐Ÿ‘ 1 views

## Background: Interleukin 6 (il-6) is a b-cell growth and differentiation factor, which may promote the growth of b-cell neoplasms. in chronic lymphocytic leukemia (cll) patients, il-6 plasma levels increased in a stage-dependent manner, suggesting that il-6 may be a useful prognostic marker. the